Project Medtech
Medtech Money
The Medtech Money Podcast produced by Project Medtech is a podcast series focused on demystifying raising and investing capital for Medtech startups. There will no longer be new episodes of Medtech Money so head over to Funding Medtech for new content.
No dejes de visitar la web del podcast y apoyar a su creador: www.projectmedtech.com
Autor
Project Medtech
Categoría
Web del podcast
Último episodio
4 de oct. de 2023
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
Episode 79: Sebastian Anastassiou, Investment Manager at Nina Capital | €62M, 3 Years, 2 Funds, 31 Portfolio Startups: Spanish Venture Capital & the Secret to Hyperfocus and Patterns 15.06.2022 1:06:30
In this episode, our host Giovanni Lauricella and our guest Sebastian Anastassiou discuss the importance of building relationships with investors, his background, Nina Capital’s link to the Stanford Biodesign program, their focus on pre-seed and seed stage companies, mechanics of how they invest, when, where, and how much, the success of the first fund and how that led to the second fund, the effe...
Episode 78: David Sylvan, President at University Hospitals Ventures | Why Hospitals are an Option for Capital: How Healthcare System Venture Arms Work and Their Added Value to Medtech 08.06.2022 59:56
In this episode, our host Giovanni Lauricella and our guest David Sylvan discuss the importance of coach-ability, why he feels he has one of the best jobs at University Hospitals, his background of how he got into investing and his role at UH, the importance of soft skills when working with teams, the various ways that University Hospitals Ventures can engage companies, the strategic focus of UH V...
Episode 77: Sam Ifergan, Founder and Managing Partner at iGan Partners | Largest Canadian Medtech VC ($500M AUM): iGan Arabia Fund Launch & Insight on VC Investment Thesis Creation 01.06.2022 1:00:02
In this episode, our host Giovanni Lauricella and our guest Sam Ifergan discuss what does it mean to be a venture capitalist in Canada, how venture capitalist come up with investment thesis’s, the most investable skill set of an entrepreneur, his own entrepreneurial story, the basics about how they invest, where they invest and average check size, the different funds at iGan Partners, why Canadian...
Episode 76: Ruben Osnabrugge, Director/Investment Manager at EQT Life Sciences | The Physician VC: How, Why, and the Value-Add to Due Diligence & The Story of a VC Firm Joining Forces with a Large PE 25.05.2022 59:53
In this episode, our host Giovanni Lauricella and our guest Ruben Osnabrugge discuss the one thing he looks for in every entrepreneur he invests in, his switch from physician to investor, where does EQT Life Sciences invest, the largest fund in Europe, what stage of company will they invest in, the value add when a physician is added to a venture capital firm, the EU MDR’s effect on innovation in...
Episode 75: JD Friedland, Partner, Cleveland Clinic Ventures | Cleveland Clinic (Ventures) Innovations: Inside-Out vs. Outside-In Approach & Investing Off the Balance Sheet Like Corporate VC 18.05.2022 1:01:58
In this episode, our host Giovanni Lauricella and our guest JD Friedland discuss the one thing JD looks for in an entrepreneur he invests in, the history of investing in Medtech and the constant changing paradigm, an overview of Cleveland Clinic Innovations, what they look for in an investment, the convergence of Medtech and digital health, how they engage with clients and how far they will suppor...
Episode 74: Mina Fahim, CEO at MediView | $9.9M or $10M SAFE Seed Round: From Engineer to Capital Raising Entrepreneur --- The Power of Social Media, Leadership & Storytelling 11.05.2022 1:10:45
In this episode, our host Giovanni Lauricella and our guest Mina Fahim discuss their $10 million seed round, the importance of trust within your company and team, the difference between timing vs. luck and the confusion between both, culture within and outside the company, how he met the company, how they raised almost $10 million in a SAFE, why investors invest in the team and storyline, get comf...
Episode 73: Tom Gerhardt, CEO at ReCross Cardio | $1.25 Million Seed Round: First-Time Founder Building a Startup and Raising Capital Between South Africa, U.S., Europe, and Israel 04.05.2022 1:20:47
In this episode, our host Giovanni Lauricella and our guest Tom Gerhardt discuss who he is and what his company is doing, what it is like being a Medtech entrepreneur in South Africa, his journey of being thrown into raising capital for the first time, the importance of getting outside your comfort zone in order to grow, how his days change so often and are never the same, who he looked for in his...
Episode 72: Keith Matheny, Serial Entrepreneur | Demystifying the Physician-Entrepreneur Stereotype: Venturing through Business 101 and Raising Capital to Bring Medtech Innovation to Patients 27.04.2022 1:03:16
In this episode, our host Giovanni Lauricella and our guest Keith Matheny discuss being a physician entrepreneur, the importance of common sense, his various companies, the downfall of physicians not getting any business training during medical school, the importance of connecting and networking, what it is like being an entrepreneur, what it was like figuring out he had to take external funding a...
Episode 71: Daniel Adler, CEO & Co-Founder at BioT | $6.5 Million Seed Round: Israeli Medtech SaaS Startup Shares the Importance of Investor Diversity and Finding a Lead Investor 22.04.2022 1:03:02
In this episode, our host Giovanni Lauricella and our guest Daniel Adler from BioT discuss what they are working on at BioT, what makes Israel’s ecosystem so great for innovation, raising a $6.5 million seed round, differences between software vs. hardware in Medtech, what can a bad board do to a company, what he has learned as an entrepreneur on how to raise capital, and so much more. Daniel Adle...
Episode 70: Tamir Meiri, Director, Venture Investments at Johnson & Johnson Innovation | J&J's Corporate Venture Arm: Full Range Investments from Company Formation to PIPEs Fueling the M&A Pipeline 20.04.2022 59:37
In this episode, our host Giovanni Lauricella and our guest Tamir Meiri from Johnson and Johnson discuss corporate venture capital, the differences between corporate venture capital and traditional venture capital, the importance of timing and luck, what an average work week looks like for him, the support one would get from JJDC beyond just money, the different geographies they invest in, how muc...
Episode 69: Hamman de Vaal, Chief Commercial Officer at AdjuCor GmbH | €29 Million Series B: The Power of Investor FOMO & How Western Startups Can Raise Capital from China using Investment Bankers --- 15.04.2022 1:21:17
In this episode, our host Giovanni Lauricella and our guest Hamman de Vaal from AdjuCor GmbH discuss what it’s like to work with an investment banker, the uniqueness of raising capital out of china, what it is like being a European Startup, bypassing a traditional series A round, negotiations with China investments, and so much more. Hamman de Vaal LinkedIn AdjuCor GmbH Website Giovanni Lauricella...
Episode 68: Catello Somma, Associate at TVM Life Sciences | $478 Million Growth Fund: What Entrepreneurs Don't Known about How Investors Conduct Due Diligence on Startups & How to Build a Pitch Deck 13.04.2022 1:03:36
In this episode, our host Giovanni Lauricella and our guest Catello Somma from TVM Life Sciences discuss what goes on behind the scenes once a startup reaches out to an investor, why they do early-stage biotech but late-stage Medtech, slide deck vs. executive summary, the importance of scientific advisory boards, what should entrepreneurs be putting in their slide deck, the due diligence process,...
Episode 67: Catherine Boule, Managing Partner at Karista | Why Digital Health is Different: European, Early-Stage, Digital Health Fund Invests on the Future for Medtech and Healthtech Converging 08.04.2022 56:53
In this episode, our host Giovanni Lauricella and our guest Catherine Boule from Karista discuss why 100% of their business plans are wrong and why this is normal for the stage of company they are investing in, where and who they invest in, what they would like to do in their next fund, their focus on digital health, challenges startups face, why they only focus on France and Western Europe, the c...
Episode 66: Graeme Smith, CEO at Lightpoint Medical | Equity and Debt Series C-2: Common Shares for All Investors & Hired CEO for Confidence, Commercialization, and Sustainability 06.04.2022 55:43
In this episode, our host Giovanni Lauricella and our guest Graeme Smith from Lightpoint Medical discuss leading a commercial stage Medtech company, taking over a startup with a goal of exiting to a strategic or going public, his experience with Cancer and the problem that they are trying to solve, the relationship with Medtech distributors, the reason for calling it a Series C1 and Series C2, the...
Episode 65: Andreas Forsland, Founder & CEO at Cognixion | $12 Million Seed Round: The Convergence of Medtech, DeepTech, and ConsumerTech 01.04.2022 1:14:18
In this episode, our host Giovanni Lauricella and our guest Andreas Forsland from Cognixion discuss how innovating at a startup vs. a large Medtech player differ, the intersection of Medtech, Deeptech, and Consumer Tech, his motivation for why he founded Cognixion, their goal of 100 million voices unlocked, the metaverse and Web 3.0, product adoption in high-tech spaces, raising capital for the fi...
Episode 64: Renee Ryan, CEO at Cala Health | Raising $77 Million as a First-Time CEO: How an Investment Banker became a Corporate Venture Investor who turned to Entrepreneurship 30.03.2022 56:43
In this episode, our host Giovanni Lauricella and our guest Renee Ryan from Cala Health discuss her background in investment banking, her transition to an investor, what they are working on at Cala Health, working with a board, closing their financing rounds, best advice for startup companies, and so much more. Renee Ryan LinkedIn Cala Health Website Giovanni Lauricella LinkedIn Project Medtech Li...
Episode 63: David Suendermann-Oeft, Co-Founder & CEO at Modality.AI | Raising Capital for SaMD: Team, Accelerators, Global Investor Syndicates, Delaware C-Corps, and Importance of "Investor Fit" 26.03.2022 1:07:02
In this episode, our host Giovanni Lauricella and our guest David Suendermann-Oeft from Modality. AI discuss what the transition was like going from academia to startup CEO, what problem his company is solving, raising capital as software as a medical device, the time it took to close the $2.1 million round, their experience with raising early-stage money, what type of investors were in their earl...
Episode 62: Soumya Mahapatra, Co-Founder & CEO at Essenvia | Medtech SaaS, Startups, and SAFEs: How a First-Time Entrepreneur Raised a $1.4 million Seed Round in Two Weeks 23.03.2022 1:04:56
In this episode, our host Giovanni Lauricella and our guest Soumya Mahapatra from Essenvia discuss what it is like to be a Co-Founder & CEO, the problem they are solving at Essenvia, SAFEs vs. Convertible note vs. Priced equity rounds, family and friends round for SaaS, how he closed a round in two weeks from his first check, why he did due diligence on his investors, and so much more. Soumya...
Episode 61: Manuel Opitz, Co-Founder & CEO at Deepeye GmbH | Software vs. Hardware and the Two-Way Street: How CEOs Save Time Raising Capital By Doing Due Diligence on Investors 19.03.2022 1:02:20
In this episode, our host Giovanni Lauricella and our guest Manuel Opitz from Deepeye discuss the importance of people when forming a Medtech startup, what they are working on at Deepeye, the advantages and disadvantages of MDR, his lessons learned while raising capital, the differences in traditional Medtech and software when raising money, the importance of doing due diligence on your investors,...
Episode 60: Antoine Papiernik, Chairman & Managing Partner at Sofinnova Partners | Think Big with "What if They Are Right?": Love for Medtech and Sofinnova's 50th Anniversary with €2,5 Billion AUM 16.03.2022 59:44
In this episode, our host Giovanni Lauricella and our guest Antoine Papiernik at Sofinnova Partners discuss the grit and time it takes to be a successful venture capital investor, his background with Sofinnova, what Sofinnova does and where they invest, why he invests in Medtech, Why Shockwave is his #1 Medtech story, the major differences between US and European investors, his thoughts on the MDR...
Episode 59: Luca Ravagnan, CEO and Co-Founder at WISE Srl | $20 Million Series C: The Semi-Full Entrepreneurial Story of a Researcher to Founder to Product Commercialization 09.03.2022 1:09:21
In this episode, our host Giovanni Lauricella and our guest Luca Ravagnan from Wise SRL discuss what his team is working on at Wise, the story of a researcher taking a company from inception to Series C, the effort that went into each round, the importance of local awards, why a mentor when you are starting out is helpful, the major learning moments going from R&D founder to CEO of commerciali...
Episode 58: Fionn Lahart, Co-Founder and CEO at OneProjects --- Raising Series A of $29 Million: The Story of Bioinnovate, Co-located Co-Founders, Venture/Grant Funding and Skipping the Seed Stage 02.03.2022 1:09:49
In this episode, our host Giovanni Lauricella and our guest Fionn Lahart from OneProjects discuss becoming an entrepreneur, the Bioinnovate program in Ireland, the product they are working on at OneProjects, how he met Christoph Hennersperger (Co-Founder)and how they deal with running a company while being located in two different countries, the naming of their rounds and why they did it the way t...
Episode 57: Robert Hamilton, Co-Founder, Chief Scientific Officer at NovaSignal Corp --- $37 Million Series C: Co-Founder Shares Business Lessons from R&D to Commercialization 23.02.2022 1:05:05
In this episode, our host Giovanni Lauricella and our guest Robert Hamilton from NovaSignal discuss the “glamour” of being a Medtech startup executive, why access to blood flow was such a problem and how he discovered the problem, the “mistake” he made in code that lead to NovaSignal, understanding how to fill your talent gaps as a founder, how he got the first money in the door, the skill set req...
Episode 56: Todd Usen, CEO at Activ Surgical --- First Time CEO Raises $72 million in 2.5 Years: Team, Tech & Fundamentals with a Slice of Humble Pie 16.02.2022 1:00:39
In this episode, our host Giovanni Lauricella and our guest Todd Usen from Activ Surgical discuss his focus on people and teamwork at Activ Surgical, his background in the Medtech space at Boston Scientific, Smith & Nephew, and Olympus Medical, what Activ Surgical is solving, how they have raised $77 million to date, what were the most important parts in raising the capital, what makes a ventu...
Episode 55: James Eadie, Managing Director at Sante --- Military Physician Turns Early-Stage Venture Capitalist: A People's Game, Love the Truth, and Be Smart about Valuations 09.02.2022 1:01:07
In this episode, Giovanni Lauricella and James Eadie discuss why he loves Medtech investing, his background in becoming an investor, what is Sante, who they invest in, how they invest, what they look for, their new $260 million dollar fund, the mechanics of investing, the importance of strategy when raising capital early, evaluations in early rounds, his advice and pitfalls and so much more. James...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos